Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
Evive Biotech Meets Endpoints in Global PIII Trial for Novel Chem... 7/9/2020
Asieris Received Chinese Approval to Start a Global Phase III Tri... 7/9/2020
Chinese Alzheimer’s Drug Rebuked Again by Top Local Neurologist 7/9/2020
GSK Files New Drug Application for IL-5 mAb Nucala (Mepolizumab) ... 7/8/2020
Sinovac Begins Phase III Trial of Its Coronavirus Vaccine in Braz... 7/8/2020
Ascentage and MSD in Clinical Trial Partnership to Evaluate APG-1... 7/6/2020
China's First COVID-19 mRNA Vaccine Approved for Clinical Trials (free) 7/1/2020
China to Initiate Use of a Controversial Covid-19 Vaccine in Its ... 6/30/2020
BeiGene's sNDA of Tislelizumab for Frontline Advanced NSCLC Accep... 6/25/2020
China's Vaccine Development Enters Phase III Trial 6/25/2020
Clover Biopharma Launches Sixth Chinese COVID-19 Vaccine Trial 6/23/2020
Bio-Thera's Avastin Biosimilar Application Accepted by NMPA 6/23/2020
IMBCAMS Begins Phase II Trial of Its Covid-19 Vaccine 6/22/2020
Roche's HBV Combo Treatment Granted Tacit Clinical Trial Approval... 6/22/2020
Sanofi Granted Chinese Approval of Dupixent (dupilumab) 6/22/2020
Ascentage Submits Its First NDA to NMPA for Third-Gen BCR-ABL Inh... 6/19/2020
NMPA Approves Clinical Trial of IMCAS's mAb Against Covid-19 6/19/2020
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin'... 6/18/2020
EMA Accepts BeiGene's Marketing Authorization Application for BRU... 6/18/2020
Snapshot of 20 Class 1 New Drugs Launched in China Since 2018 6/17/2020
Yisheng unveils PIKA adjuvanted recombinant protein vaccine candi... 6/17/2020
SinoPharm/CNBG Reports Positive Outcome of Early Data on Covid-19... 6/17/2020
Sinovac Reports Positive Early Data of Its Covid-19 Vaccine (free) 6/16/2020
Amgen/BeiGene's Joint Chinese IND Application for AMG 160 Accepte... 6/12/2020
CDE Accepts Import Application of Firazyr from Takeda/Shire 6/12/2020
CDE Accepts Import Application of Antiviral Xufluza from Roche an... 6/11/2020
MSD Gains IND Approval for Prevymis (Letermovir) in China 6/10/2020
CASI Pharma Submits IND To Conduct Phase 1 Study For Anti-38 mAb ... (free) 6/8/2020
Harbour BioMed Announces IND Approval for HBM9161 by NMPA 6/3/2020
Innovent Announces the Preliminary Results of the Anti-CTLA-4 Mon... 6/3/2020
Page:1/6    Total number of articles:172  :[1][2][3][4][5][>>][End]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links